Copied from IndPharm. Dr Vijay Thawani ... 3rd Workshop on "Advance Techniques of Molecular Biology" March 7-9, 2008 FOCUS: through lectures and practical...
Hi, The topic does not seem to be stirring any reactions. Well I will do my part. In the budget proposal for next financial year in India, Tax has been REDUCED...
hello Vijay , I agree with you that saying medicine prices will be reduced is only an eyewash. We were told that after signing the patent treaty also , the...
Hi Kunda, Thanks for your posting. The reduction in excise duty is expected to result in decrease of price patient pays (PPP) by approximately 5% but I am...
Further to my posting on the subject, the budgettary proposal boasts of "Excise duty on pharmaceutical sector reduced from 16 per cent to 8 per cent" (see:...
Hi, On behalf of NetRUM I cordially invite Dr Mangesh Bankar to moderate the discsussion on "Therapeutic utility of monoclonal antibodies" from 03 March to 08...
Dear Members. First of all I am extremely thankful to my Mentor Dr. Vijay Thawani Sir for giving me this opportunity for conducting the discussion on netrum. I...
Dear Members. First of all I am extremely thankful to my Mentor Dr. Vijay Thawani Sir for giving me this opportunity for conducting the discussion on netrum. I...
Dear Mangesh, Nice to know that you are moderating this discussion. Some uses of MAb are enclosed. A sketch of how MAb are made is attached. Anupama Some...
Hi Dr Bankar, My immediate reaction is to congratulate Dr Vijay for mentoring people like you, i think you have started the discussion well. Be not worry...
Hello friends, I have recently joined netrum group on yahoo. Its nice being part of you. Can we add each other in our messenger list so that we can chat live...
Dear sir, Thank you for your encouraging words. I am certainly agreed with your comment regarding the high treatment cost of monoclonal antibodies. The costs...
Hi all, Sorry Mangesh to disturb the discussion for essential comments on Essential Medicines.The propsal on taxation on EM has been made in the budget....
Dear Anupama, I am really glad to see your succinct and expeditious reply- the kind of reply I think everyone will expect at the start of discussion. We came...
Dear Dr. Mangesh Well begun. Perhaps the earliest successful use of Monoclonal Antibodies are for treating Digoxin toxicity , commercially available as...
To Mahadev Desai, I really liked ur optimism regarding MAbs cost reduction in the coming future. Rituximab is beneficial in several diseases which you have...
Hello Prof Vijay Thawani & Fellow Members, It is good to be in touch. Those remembering me from the RDU course I did in Jaipur, India, will know that I work...
Dear Madam, You are certainly welcome to have stated your exemplary concerns regarding the benefit of the people of S. Africa. Off-label use of a medicine...
Hi, Further to my previous post I share the news below, sent by our NetRUMian Dr Jayesh. It speaks of the shirking responsbility by the medicine exporting...
Hello all, Monoclonal antibody therapy is a form of passive immunotherapy. The combination of a mouse B cell that can recognize a particular antigen and a...
Dear Dr Banker Your detailed response is welcome and stimulating. I will have to source information on re-imbursement by medical aids/agencies for off-labelled...
Thank you, Vijay, for the invitation to share experiences. In the making of medicines for human and animal consumption, there can be no compromise in the...
Dear Smita, I was agog over such a reply from any young PG student. It is a reflection of your assiduous toil for detailed net search and I am certainly sure...
Hello Dr Mangesh, Thank you for your kind words. The information in the former post was just basic introduction to MABs which may be well known. MABs is...
Dear Smita, You have provided a very nice link to explain MAb production. Yes, monoclonal antibodies are considered as targeted therapies, and they should have...
Dear Mariam Cassimjee, Thanks to the knowledgeable poster like you for taking the time to contribute to this discussion. We will be happy to hear more comments...
Dear All, Its good to know that young PG students are researching thorugh the internet to find out so many safety issues that we in the West already know about...
Dear Madam, I concur with all the salient concerns made by you regarding our National Pharmacovigilance Programme (NPP). Current poor status of NPP may have...